Back to top

Analyst Blog

UnitedHealth Group Inc. (UNH - Analyst Report) reported its second-quarter 2013 earnings of $1.40 per share, higher than the Zacks Consensus Estimate of 1.26 per share. Earnings were also up 7.4% on a year-over-year basis.

Better-than-expected earnings came on the back of lower expenses as well as higher enrollment. Results reflected a solid performance from its health benefits business along with strong growth from Optum segment.

Net income was up 7.4% year over year to $1.44 billion, or $1.40 on a per share basis.

UnitedHealth posted revenues of $30.4 billion, up 11.4% year over year but down from $30.5 billion as per the Zacks Consensus Estimate. The year-over-year increase was an outcome of broad-based organic growth and business expansion in both health care benefits and health care services.

A higher revenue growth rate in governmental benefit program offerings during the quarter led to a 20 basis points increase in UnitedHealth’s medical care ratio increase to 81.5%.

Segment performance

During the reported quarter, UnitedHealth’s health benefits segment – UnitedHealthcare – witnessed revenue growth of 11.0% year over year to $28.3 billion. Earnings from operations remained unchanged at $1.9 billion.

Revenue from the company’s other segments – the health services segment branded as Optum – improved 21% to $8.8 billion on a year-over-year basis. Earnings from operations, however, surged 68% year over year to $536 million. Continued progress on Optum’s plan to accelerate growth and improve margins and productivity by strengthening integration and business alignment aided the improvement.

Membership Enrollment

UnitedHealth ended the quarter with 45 million members, up 9.125 million year-over-year.

Other Highlights of the quarter

During the quarter, UnitedHealth finished the final steps in the acquisition of Amil. The company also raised its quarterly dividend by 32% to a $1.12 per share annually.

Capital Position

Cash flow from operations was $1.5 billion in the quarter, up 8.6% year over year.

UnitedHealth also expects cash flows in a range of $7.2 billion to $7.6 billion for 2013.

The company ended the quarter with debt to equity ratio of 34.6% down 1.6% during the quarter.

Share Repurchases and Dividend

UnitedHealth Group spent $791 million to buyback 13 million shares in the quarter. The company paid $281 million in dividends to shareholders.

2013 Guidance

UnitedHealth increased the lower range of its earlier 2013 EPS forecast. It now expects earnings per share of $5.35 to $5.50. The company reiterated its 2013 revenue expectation of $122 billion. 

The company also expects cash flows in a range of $7.2 billion to $7.6 billion.

Our take

UnitedHealth is one of the biggest players in the health insurance industry.  The company is considered to be the bellwether for the industry and is the first company to kick start earnings for the health insurance sector. The company has showed a favorable performance for the first half of 2013. It is best placed to benefit from the changing health insurance market. Last week the company announced to double its Accountable Care Contracts to $50 billion by 2017. The company is taking strategic steps for long term growth, which we believe will reap benefit going forward.
 

UnitedHealth carries a Zacks Rank# 2 (Buy). Other players WellPoint Inc. (WLP - Analyst Report), Aetna Inc. (AET - Analyst Report), CIGNA Corp. (CI - Analyst Report) are also expected to release their second quarter earnings shortly.   
 

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
UTD THERAPE… UTHR 117.83 +28.51%
TRIQUINT SE… TQNT 20.67 +6.52%
RF MICRO DE… RFMD 12.47 +6.04%
VASCO DATA… VDSI 14.77 +4.68%
BANCO DO BR… BDORY 15.53 +3.95%